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A B S T R A C T
In the past decade, calcium phosphate (CaP) ceramics have emerged as alternatives to autologous bone grafts for
the treatment of large, critical-sized bone defects. In order to be effective in the regeneration of such defects,
ceramics must show osteoinductive behaviour, defined as the ability to induce de novo heterotopic bone for-
mation. While a set of osteoinductive CaP ceramics has been developed, the exact processes underlying os-
teoinduction, and the role of the physical and chemical properties of the ceramics, remain largely unknown.
Previous studies have focused on the role of the transcriptome to shed light on the mechanism of osteoinduction
at the mRNA level. To complement these studies, a proteomic analysis was performed to study the behaviour of
hMSCs on osteoinductive and non-osteoinductive CaPs. The results of this analysis suggest that plasma cell
glycoprotein 1 (PC-1), encoded by the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) gene,
plays a key role in the process of osteoinduction by CaP ceramics. Validation experiments have confirmed that
indeed, the mRNA expression of ENPP1 and the production of PC-1 are higher on osteoinductive than on non-
osteoinductive CaP ceramics, a trend that was also observed for other osteogenic markers such as bone mor-
phogenetic protein 2 (BMP2) and osteopontin (OPN), but not for alkaline phosphatase (ALP). Our results also
showed that the expression of PC-1 is restricted to those cells which are in direct contact with the CaP ceramic
surface, plausibly due to the localised depletion of calcium and inorganic phosphate ions from the supersaturated
cell culture medium as CaP crystallises on the ceramic surface. Replicating the surface of the osteoinductive
ceramic in polystyrene resulted in a significant decrease in ENPP1 expression, suggesting that surface structural
properties alone are not sufficient to induce ENPP1 expression. Finally, knocking down ENPP1 expression in
hMSCs resulted in increased BMP2 expression, both at the mRNA and protein level, suggesting that ENPP1 is a
negative regulator of BMP-2 signalling. Taken together, this study shows, for the first time, that ENPP1/PC-1
plays an important role in CaP-induced osteogenic differentiation of hMSCs and thus possibly osteoinduction by
CaP ceramics. Furthermore, we have identified a crucial role for the interfacial (chemical) events occurring on
the CaP ceramic surface in the process of osteoinduction. This knowledge can contribute to the development of
new bone graft substitutes, with improved osteoinductive potential.
1. Introduction
Due to a growing world population, improved quality of life, and
increased life expectancy, the incidence of large, critical-sized bone
defects is increasing. These defects, caused by trauma, infection, or
resection of tumours, are unable to regenerate without clinical
intervention [1]. Currently, the standard intervention takes the form of
implantation of bone harvested either from elsewhere in the patient (an
autograft) or from a donor (an allograft). These methods have serious
disadvantages, including limited availability and the risk of infection
and of complications from the second surgery required to harvest bone
for autografting. Therefore, they are steadily being replaced by
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alternative methods, particularly involving the use of synthetic bone
graft substitutes [2]. In contrast to autografts or allografts, synthetic
substitutes have lower health risks, essentially unlimited availability,
and are relatively inexpensive to produce and store. However, in order
to fully replace natural bone grafts, these substitutes must also at least
match their efficacy in promoting the healing of large bone defects. This
efficacy depends largely on the osteoinductive potential of the material-
that is, its ability to trigger differentiation of undifferentiated stem and/
or progenitor cells into the osteogenic lineage, resulting in de novo bone
formation [3,4].
Calcium phosphate (CaP) ceramics are now the leading alternative
to natural bone grafts, as they closely resemble natural bone mineral,
and exhibit excellent biocompatibility, osteoconductivity and bone-
bonding properties [5,6]. Moreover, some CaP ceramics have been
shown to possess intrinsic osteoinductivity due to their physical and
chemical properties. A range of CaP ceramics, including beta-tricalcium
phosphate (β-TCP) [7], hydroxyapatite (HA) [8], biphasic calcium
phosphate combining β-TCP and HA [9], carbonated apatite [10], oc-
tacalcium phosphate [11], and dicalcium phosphate dihydrate [12],
have been shown to induce heterotopic bone formation, the defining
characteristic of osteoinductivity, in a variety of in vivo models. How-
ever, the mechanism by which these materials elicit this biological re-
sponse remains poorly understood, and it is not yet known exactly
which physical or chemical properties are necessary or sufficient for
osteoinduction.
In order to understand the osteoinduction mechanism, researchers
have hitherto focused on the role of endogenous factors such as bone
morphogenetic proteins (BMPs) [13,14], to date the best known os-
teoinductive growth factors [15]. Several studies have suggested that
the inflammatory response plays an important role [16,17]. It is clear
that some combination of physical and chemical properties of the ma-
terial is required for osteoinduction - chemically identical ceramics can
show different degrees of osteoinduction depending on their surface
microstructure [3,18,19], while almost all known osteoinductive ma-
terials contain calcium phosphates, suggesting an important role for
surface chemistry. The different mechanisms proposed for osteoinduc-
tion by biomaterials, and the role of specific material properties in each
of these mechanisms, are described in recent reviews [20,21]. Very
recently, a new mechanism has been suggested whereby osteoinduction
is triggered by a localised depletion of calcium and phosphate ions from
body fluid which is normally supersaturated with respect to these ions
[22], in contrast to previously suggested mechanisms based on a loca-
lised increase in dissolved calcium and phosphate concentration close
to a CaP-containing material.
In a recent study in our lab, we investigated how a series of bio-
materials with known osteoinductive potential modulated the tran-
scriptome of osteoblast-like MG63 cells [23]. We correlated tran-
scriptomic changes with individual properties, thus identifying subsets
of genes controlled either by physical surface structure or by chemical
composition of the ceramics. This study yielded important information
on the cell response to osteoinductive materials at the mRNA level, but
the protein interactions involved in this response remain unknown.
To obtain an insight into the interaction of cells with osteoinductive
ceramics at the protein level, we investigated the response of bone
marrow-derived human mesenchymal stromal cells (hMSCs) to four
CaP ceramics with known osteoinductive potential by performing a full-
proteome analysis. Two of the ceramics used (HA and BCP1300) were
known not to be osteoinductive, while the other two (TCP and
BCP1150) were known to be osteoinductive. Note that BCP1150 and
BCP1300 are chemically identical and differ only in their surface mi-
crostructure.
Based on this analysis, we identified a set of 1090 proteins that are
expressed differentially on osteoinductive versus non-osteoinductive
CaP ceramics. From these proteins, we identified plasma cell glyco-
protein 1 (PC-1) as a protein of interest for further studies. PC-1 is a
type II transmembrane glycoprotein, encoded by the ectonucleotide
pyrophosphatase/phosphodiesterase 1 (ENPP1) gene, which is involved
in the regulation of tissue mineralisation. PC-1 controls phosphate
homeostasis, mainly by hydrolysing adenosine triphosphate (ATP) into
adenosine monophosphate (AMP) and pyrophosphate (PPi) [24],
though it also hydrolyses ATP to adenosine diphosphate (ADP) and
inorganic phosphate (Pi) to a much lesser extent.
It has been suggested that the balance between extracellular Pi and
PPi is involved in the control of tissue calcification, as excess PPi results
in decreased bone mineralisation, while PPi deficiency results in excess
mineral formation [25]. Therefore, the production of PPi by PC-1 can
be considered to negatively regulate tissue mineralisation [26]. In vivo,
bone mineral initially forms by the spontaneous precipitation of cal-
cium and phosphate to form crystalline HA in the matrix vesicles (MVs)
of osteoclasts. These are organelles from which PPi is excluded, and
where if necessary additional Pi can be formed by the hydrolysis of
organic phosphate compounds by phosphoethanolamine/phos-
phochioline phosphatase (PHOSPHO1). Crystals of HA formed in the
MVs then enter the extracellular fluid, where they can nucleate further
HA crystallisation. This further crystallisation is negatively regulated by
PPi, which is transported out of cells by the ANK (ankyloses protein)
[27,28]. Mutations in ENPP1 or ANK have been shown to cause hy-
permineralisation disorders in mice [27,29], both due to a deficiency of
extracellular PPi and (in the case of ENPP1) due to an interaction with
Hedgehog signalling.
Given the role of ENPP1 and its product PC-1 both in orthotopic
bone development and in the regulation of heterotopic mineralisation,
we aimed to elucidate its role in the response of hMSCs to the presence
of osteoinductive CaP ceramics, and to define the role of individual
material properties in eliciting this response.
2. Materials and methods
All reagents were obtained from appropriate commercial suppliers
and used as received without further purification unless otherwise
stated.
2.1. Calcium phosphate ceramics
The CaP ceramic particles used in this study had a diameter of
2–3mm. Hydroxyapatite (HA), beta-tricalcium phosphate (TCP), and
two biphasic calcium phosphates consisting of HA and TCP sintered at
1150 °C (BCP1150) and 1300 °C (BCP1300), were produced using a
procedure described previously [30]. Briefly, HA particles were pro-
duced from commercially available HA powder (Merck Eurolab BV,
Amsterdam, the Netherlands) by dual-phase mixing as previously de-
scribed and sintered at 1250 °C for 8 h. TCP particles were prepared
from TCP powder (Plasma Biotal, Plasma Coating Ltd., Tideswell, UK)
using the H2O2 method and sintered at 1100 °C. The two BCP ceramics
were prepared from a combination of TCP powder (Plasma Biotal) and
calcium-deficient apatite powder (produced in-house) using the same
method and sintered at 1150 °C and 1300 °C to produce BCP1150 and
BCP1300 respectively.
Ceramic discs with a thickness of 1mm were produced from ceramic
cylinders produced in-house using the same methods as above with a
diameter of 9mm using a diamond saw microtome (SP-1600, Leica,
Wetzlar, Germany). All ceramic materials were sterilised by autoclaving
before use.
2.2. Collagen coating of CaP ceramics
Rat tail collagen type I (Fisher Scientific, Landsmeer, the
Netherlands) was diluted in 0.02M acetic acid to a final concentration
of 50 μg/mL and sterilised by 0.2 μm filtration. Sterile ceramic discs
were dipped into the collagen solution for 10 s, air-dried for 1 h at room
temperature and gently washed twice with sterile PBS.
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2.3. Structural replicas of ceramics in polystyrene
Polystyrene replicas of the ceramic discs were fabricated by replica
moulding using a polydimethylsiloxane (PDMS) mould, following a
method similar to those described earlier [31–33]. In short, the PDMS
mould was prepared by casting a 10:1 w/w mixture of PDMS base and
crosslinker (Sylgard 184, Dow Corning, Midland, MI, USA) over a
ceramic disc on a glass slide and cured at 80 °C for 2 h. Polystyrene
pieces with a size of approximately 2×2 cm were cut from the bottom
of a Petri dish and moulded to the PDMS at 150 °C for 1 h between two
glass slides pressed together using office clips, using a Teflon sheet to
ensure release of the polystyrene from the glass slide. Excess poly-
styrene was cut off to leave discs with similar dimensions to the original
ceramic discs.
2.4. Cell culture
hMSCs were isolated from bone marrow aspirates obtained from
donors who had given written informed consent. After isolation, hMSCs
were expanded in proliferation medium, which consisted of basic
medium (α-MEM (Life Technologies, Bleiswijk, the Netherlands), 10%
v/v foetal bovine serum, 0.2 mM ascorbic acid (Life Technologies),
2 mM L-glutamine (Life Technologies), 100 U/mL penicillin (Gibco,
Landsmeer, the Netherlands) and 100mg/mL streptomycin (Gibco),
supplemented with 1 ng/mL basic fibroblast growth factor (bFGF)
(Instruchemie, Delfzijl, the Netherlands). During culture, the cells were
incubated at 37 °C in a humidified atmosphere with 5% CO2 and
medium was refreshed every 3–4 days.
For RT-qPCR analysis, hMSCs were cultured in either basic medium
or osteogenic medium (basic medium supplemented with 1 μM dex-
amethasone). For Western blot, immunohistochemistry and nano LC-
MS analyses, cells were cultured in osteogenic medium. 2× 105 hMSCs
were seeded onto either three ceramic particles or a single 63.5mm2
ceramic or polystyrene disc, and cultured for 8 h, 48 h or 7d as detailed
in the results section. Each experiment was repeated at least twice and
included a minimum of 3 replicates.
For transfection experiments, 1× 105 hMSCs were seeded on three
TCP ceramic particles and cultured in osteogenic medium for 4 h. After
4 h, cells were infected with viral particles containing either short
hairpin RNA (shRNA) constructs targeting ENPP1 or scramble shRNA as
a control, and cultured for a further 7 d.
2.5. Full proteome analysis by nano liquid chromatography - mass
spectrometry (nLC-MS)
Samples were trypsinised according to standard procedure. For each
sample, 20 μL of trypsinised cells was added to 20 μL of 0.1% Rapigest
(Waters Chromatography, Etten-Leur, the Netherlands) in 100mM
triethylammonium bicarbonate (TEAB) buffer with a pH between 7.5
and 8. Samples were sonicated for 2min using an ultrasonic cell dis-
ruptor at 70% power, then heated to 95 °C for 5min. Samples were then
reduced with DTT (dithiothreitol, 1 μL of a 100mM solution, 30 min,
60 °C), cooled, and alkylated with 1 μL of 300mM iodoacetamide (IAA)
in the dark for 30min, before being incubated overnight at 37 °C with
2 μL of a 50 ng/mL trypsin solution. The reaction was then quenched
and RapiGest hydrolysed by the addition of 0.5 μL 25% trifluoroacetic
acid (TFA). The pH of the solution was adjusted to 2, and samples
centrifuged at 20,800 x g for 20min.
Mass spectrometry measurements were performed on an Ultimate
3000 nanoLC system (Dionex, Germering, Germany) coupled to a hy-
brid linear ion trap/Orbitrap mass spectrometer (LTQ Orbitrap XL,
Thermo Fisher Scientific, Bremen, Germany). 1 μL of digest was loaded
onto a C18 trap column (PepMap C18, 300 μm ID x 5mm length, 5 μm
particle size, 100 Å pore size; Dionex) and desalted for 10min with
20 μL/min 0.1% TFA. The trap column was then switched into line with
the analytical column (PepMap C18, 75 μm ID x 150mm length, 3 μm
particle size, 100 Å pore size; Dionex). Peptides were eluted with a flow
rate of 300 nL/min and a binary gradient of 0–25% solvent B over
120min, followed by 25–50% solvent B over 60min, where solvent A
was 2% acetonitrile and 0.1% formic acid in water, and solvent B was
80% acetonitrile and 0.08% formic acid in water. A data-dependent
acquisition method was used, with an initial high-resolution survey
scan from m/z 400 to 1800 with the value of the automatic gain control
(AGC) set to 106, resolution of 30,000 atm/z 400, and lock mass set to
445.120,025 u (protonated (Si(CH3)2O))6). Based on this survey, the 5
most intense ions were consecutively isolated (AGC target set to 104)
and fragmented by collision-activated dissociation applying 35% nor-
malised collision energy in the linear ion trap. After precursors were
selected for MS/MS, they were excluded from further MS/MS spectra
for 3min.
Raw data were preprocessed using the Progenesis 4.0 software
package (Nonlinear Dynamics, Newcastle-upon-Tyne, UK). Peptides
were identified and assigned to proteins by exporting features using
Bioworks 3.2 (Thermo Fisher, Germany). The resulting file was sub-
mitted to Mascot v2 (Matrix Science, London, UK) for identification
using the UniProt Homo sapiens database (release 2013_07, containing
20,265 sequences). Only ions with a charge between +2 and + 8 were
considered, and only proteins with at least two unique peptides (Mascot
ions score> 25, corresponding to a peptide probability cutoff of 0.01)
were accepted as identifications. Carbamidomethylation of cysteine
was set as fixed, and oxidation of methionine as variable, allowing for a
maximum of 2 missed cleavages. Mass tolerance was set to 10 ppm for
precursor ions and 0.2 Da for fragment ions. Mascot search results were
imported back into Progenesis to link identified peptides to their de-
tected abundances, which were normalised to the total ion current to
compensate for experimental variations.
Scaffold (Proteome Software Inc., Portland, OR, USA) was also used
to validate protein identifications derived from MS/MS results. This
software verified peptide identifications using the X!Tandem database
searching program [34,35]. Peptide identifications were probabil-
istically validated using PeptideProphet [36] and corresponding protein
probabilities derived using ProteinProphet [37,38].
2.6. Real-time quantitative PCR analysis
Total RNA was isolated from hMSCs using a NucleoSpin RNA II kit
(Macherey-Nagel, Düren, Germany) according to the manufacturer's
instructions, and its concentration measured using a nanoDrop spec-
trophotometer (Thermo Fisher). Reverse transcription of cDNA from
370 ng mRNA was performed using an iScript cDNA Synthesis Kit (Bio-
Rad, Hercules, CA, USA). Gene expression was normalised to GAPDH,
and relative changes in expression were calculated using the ΔCT
Table 1
Sequences of primers used for RT-qPCR.
Gene Target Primer Sequence
ENPP1 (F) 5' - CAGCGACCTTTGCAACTTTT (R) 5' - CCAAGGACCCCAACACCTA
BMP2 (F) 5' - ACTACCAGAAACGAGTGGGAA (R) 5' - GCATCTGTTCTCGGAAAACCT
OPN (F) 5' - CTCCATTGACTCGAACGACTC (R) 5' - CAGGTCTGCGAAACTTCTTAGAT
ALP (F) 5' - ACAAGCACTCCCACTTCATC (R) 5' - TTCAGCTCGTACTGCATGTC
GAPDH (F) 5' - CGCTCTCTGCTCCTCCTGTT (R) 5' - CCATGGTGTCTGAGCGATGT
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method. Primer sequences used are summarised in Table 1.
2.7. Western blot analysis
Cells cultured on biomaterials were lysed directly from the cell-
material constructs using the Ripa lysis buffer system (Santa Cruz
Biotechnology, Dallas, TX, USA). Protein concentration was determined
using a bicinchoninic acid (BCA) assay kit (Pierce, Rockford, IL, USA)
according to the manufacturer's instructions. Equivalent amounts of
protein were separated by SDS-PAGE on a 15% gradient precast poly-
acrylamide gel (Biorad; 1.5 h, 200 V, 100mA), then transferred onto a
mini format 0.2 μm PVDF membrane (Bio-Rad) using a Trans-Blot
Turbo system (Bio-Rad) at 25 V and 1.3 A for 7min. The membrane was
blocked using 5% non-fat dried milk in Tris-buffered saline (TBS) for
1 h, before incubation with primary antibodies for 16 h at 4 °C, and with
secondary antibodies (horseradish peroxidase-conjugated goat anti-
rabbit or anti-mouse, Bio-Rad) for 1 h at room temperature. The mem-
brane was incubated with chemiluminescent detection reagent (Pierce)
for 1min, then developed with the FluorChem M system
(ProteinSimple, San Jose, CA, USA). The primary antibodies used were
rabbit anti-human PC-1 polyclonal (Santa Cruz), rabbit anti-human
BMP2 polyclonal (Thermo Fisher) and mouse anti-human GAPDH
polyclonal (Santa Cruz).
2.8. Immunofluorescence analysis
After 7d of culture, the cell-ceramic constructs were fixed with 4%
w/v paraformaldehyde for 15min at room temperature, then washed
twice with PBS. Samples were then decalcified in 4% formic acid for 2-
3d, dehydrated using an ethanol series, embedded in paraffin, and cut
into 5 μm sections. Sections were deparaffinised in xylene and rehy-
drated using an ethanol series, before being incubated overnight at
room temperature with rabbit anti-human PC-1 primary antibody
(Santa Cruz) diluted 1:100 in PBS with 1% BSA. Alexa Fluor 488-con-
jugated donkey anti-rabbit IgG (Fisher) was used as the secondary an-
tibody, and nuclei stained with DAPI (Sigma). Sections were mounted
using standard techniques and imaged using Nikon Eclipse E600 and
Nikon confocal A1/super resolution N-STORM microscopes (Nikon
Europe, Amsterdam, the Netherlands; BioNanolab, University of
Twente, Enschede, the Netherlands). DAPI (excitation at 360 nm,
emission at 460 nm, blue) and Alexa Fluor 488 (excitation at 495 nm,
emission at 519 nm, green) signals were collected and merged into
single images.
2.9. Laser capture microdissection
Samples were processed for immunofluorescence as detailed above,
except that polyethylene naphthalene (PEN) membrane slides were
used instead of conventional glass histology slides. Laser capture mi-
crodissection was performed as described previously [39]. Briefly,
slides were washed 3 times with PBS, air-dried and placed on a PALM
Microbeam IV laser microdissection system (Zeiss, Jena, Germany),
with AdhesiveCap 500 (Zeiss) used to collect cut tissues. Both tissues
containing hMSCs in direct contact with the ceramic surface and tissues
containing cells from the ceramic pore, which were not in direct contact
with the surface, were selected. Samples were dissolved in 20 μL di-
gestion buffer containing 0.1% RapiGest (Waters) and 100mM TEAB,
and stored at −80 °C until they were analysed using nLC-MS as de-
scribed above.
2.10. ENPP1 silencing by shRNA
The RNAi Consortium (TRC) human lentiviral shRNA libraries with
clone ID TRC TRCN0000002537 were obtained from Dharmacon
(Lafayette, CO, USA). Control constructs were scrambled with sh se-
quence CCTAAGGTTAAGTCGCCCTCG in plko.1-puromycin. Lentivirus
particles were produced according to a literature protocol [40]. Briefly,
HEK293FT cells were transfected with the plko.1 construct using the
packaging plasmids pcmv-VSV-G and psPax2 and the transfection re-
agent PPei (Polysciences, Warrington, PA, USA). Virus particles were
collected 48 h post-transfection, filtered through a 0.45 μm membrane
and snap-frozen until they were used in functional studies.
2.11. Elemental analysis of cell culture media by ICP-MS
Concentrations of calcium and phosphorus in cell culture medium
were quantified by ICP-MS (iCaP Q, Thermo Scientific). 1 mL of
medium was collected from each set of cell culture conditions (un-
coated and collagen-coated HA and TCP), and from an empty well as
control, before medium refreshment at 2 d, 5 d and 7 d of culture, and
stored at−30 °C until analysis. Samples were thawed, vortexed for 30 s,
and diluted 1:50 in 1% HNO3 with the addition of 20 ppb scandium as
internal standard. Quantification was performed in KED mode with He
as collision gas. A standard curve of 100, 200, 500 and 5000 ppb P and
Ca was prepared in the same matrix medium as the samples, and fresh
cell culture medium from the same batch was used as the blank. Data
were expressed relative to concentrations in fresh cell culture medium.
2.12. Statistical analysis
Data were analysed using GraphPad Prism 6.0 as detailed in the
Results section. One-way ANOVA with Tukey's post-hoc test was used
for all cell culture experiments with the exception of ENPP1 knock-
down. Two-way ANOVA with Tukey's post-hoc test was used for ICP-MS
experiments, Student's T-test for ENPP1 knockdown experiments, and
Fisher's exact test for the comparison of proteomics data after micro-
dissection. For proteomics data, two-way ANOVA with Bonferroni's
post-hoc test was applied. Differences were considered to be significant
if the p-value was<0.05.
3. Results
3.1. Identification of proteins expressed by hMSCs on CaP ceramics with
different osteoinductive potential using proteomics
hMSCs from one donor were cultured on two osteoinductive cera-
mics (TCP and BCP1150) and two non-osteoinductive ceramics (HA and
BCP1300) for 8 h, 48 h and 7d in osteogenic medium, followed by a full
proteomic analysis using nLC-MS.
Fig. 1 shows the top 50 proteins overexpressed after 7d in hMSCs
cultured on the osteoinductive ceramics (TCP and BCP1150) compared
to hMSCs cultured on the non-osteoinductive ceramics (HA and
BCP1300). It was also shown that most of these proteins were over-
expressed in hMSCs on all CaP ceramics (both osteoinductive and non-
osteoinductive) compared to control experiments where hMSCs were
cultured on 2D tissue culture polystyrene plates. This suggests a role for
either the 3D environment or the presence of non-specific CaP in their
regulation.
The Gene Ontology term enrichment analysis of the data for bio-
logical process, cellular component, and molecular function, as well as
the pathway analysis were performed and will be published separately.
In the top-50 list, PC-1, which is known to be involved in the reg-
ulation of tissue mineralisation [41] and osteogenic differentiation [42]
was identified as a protein of interest. Another interesting protein
identified was Matrix Gla-Protein (MGP) which has a role in vascular
calcification [43] and endochondral ossification [44]. The potential
role of MGP in osteoinduction will be investigated separately.
3.2. Validation of overexpression of ENPP1 mRNA and PC-1 on
osteoinductive ceramics
To measure the change in expression of ENPP1 and PC-1 on
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osteoinductive compared to non-osteoinductive CaP ceramics, hMSCs
were cultured on the two osteoinductive (TCP and BCP1150) and the
two non-osteoinductive (HA and BCP1300) ceramics in osteogenic
medium for 8 h, 48 h and 7d. Expression levels of ENPP1 and PC-1 were
measured by RT-qPCR and Western immunoblotting respectively
(Fig. 2).
Before 7d, expression levels of PC-1 were the same across the four
ceramics. At 48 h, the level of ENPP1 mRNA was increased on TCP, but
not on BCP1150, compared to the non-osteoinductive ceramics.
However, by 7d, expression levels of both ENPP1 and PC-1 were higher
on osteoinductive than on non-osteoinductive ceramics. This effect was
also observed when cells were cultured in basic (non-osteogenic)
medium (Fig. S1), so can be considered to be independent of the cell
culture medium used.
In addition, mRNA levels of the well-established osteogenic markers
BMP2, OPN and ALP were measured by RT-qPCR after 7d to determine
whether these also showed differential expression on the four ceramics
(Fig. S2). These measurements showed a significant upregulation of
OPN on both TCP and BCP1150, and of BMP2 on TCP, compared to the
non-osteoinductive ceramics. This is in accordance with previous ex-
periments [4]. In contrast, ALP showed similar expression levels across
all four ceramics, but this is again in accordance with previous studies
which have shown that ALP is not upregulated in the presence of os-
teoinductive ceramics [45].
In general, these results have shown that, like other known markers
of osteogenic differentiation, ENPP1 and PC-1 are upregulated on os-
teoinductive compared to non-osteoinductive ceramics.
3.3. Spatial distribution of hMSCs expressing PC-1
In the previous section, we showed that ENPP1 and PC-1 are upre-
gulated in hMSCs cultured on osteoinductive ceramics relative to those
cultured on non-osteoinductive ceramics. Cells cultured on 3-D
materials such as the ceramics used in this study often exhibit pheno-
typic heterogeneity depending on their position within the 3-D con-
struct. Therefore, we set out to determine if the increased PC-1 ex-
pression levels were restricted to a spatially distinct subpopulation of
cells on the osteoinductive ceramics. After 7d of culture in osteogenic
medium, samples were decalcified and immunohistochemically stained
for PC-1 (Fig. 3). Cells expressing PC-1 were almost absent on the non-
osteoinductive ceramics, as expected from the Western blot results. In
contrast, on both osteoinductive ceramics, PC-1+ cells were exclusively
observed in direct contact with the surface of the osteoinductive
ceramic. Cells within the pores of the ceramic, but not in direct contact
with its surface, did not express PC-1 (see Fig. 3).
To further confirm these observations, we isolated the PC-1+ cells
by laser microdissection and obtained a proteomic profile by LC-MS/MS
analysis. This was compared with a similar profile of cells isolated from
the pores of the ceramic. These results confirmed the presence of two
distinct subpopulations of cells on osteoinductive ceramics. PC-1 ex-
pression is restricted to those cells in direct contact with the surface. 77
other proteins were also found to be expressed exclusively in this sub-
population, while 11 were found to be expressed exclusively in the
subpopulation of cells in the ceramic pores with no contact with the
surface (Table S2). In addition, 41 proteins were found to have different
expression levels between the two subpopulations (Table S3).
Overall, these results confirmed that only the subpopulation of
hMSCs in direct contact with the surface of an osteoinductive ceramic
express PC-1, and that these cells have a different proteomic profile
from the cells not in contact with the surface.
3.4. Effect of surface modification with collagen on the expression of ENPP1
Having determined that direct contact with the ceramic surface
affects the expression of PC-1, we next investigated the effect of the
surface chemistry of the ceramic on this relationship. HA and TCP
Fig. 1. An overview of the 50 proteins
identified as having the largest difference in
abundance between hMSCs cultured on os-
teoinductive TCP and BCP1150 and those
cultured on non-osteoinductive HA and
BCP1300 after 7 d culture in osteogenic
medium. Proteins are sorted from 1 (most
significant) to 50 (least significant) based on
the statistical significance of differential
expression (n=3, ANOVA with Bonferroni
post-hoc test). Each block represents a bio-
logical replicate. MGP=Matrix Gla
Protein; PC1 = Plasma cell glycoprotein 1.
The complete list of proteins is given in the
Supplementary Information.
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ceramic discs were dip-coated with collagen in order to ‘cover’ the CaP
surface chemistry and replace it with collagen surface chemistry.
Scanning electron microscopy (SEM) imaging of the ceramic discs be-
fore and after the coating process suggested that a very thin collagen
layer was deposited on the ceramic surface (Fig. S3). Further optical
profilometry analysis showed a small to non-existent difference in ar-
ithmetic mean height (Sa) between uncoated and collagen-coated HA
and TCP ceramics, whereas both ceramics exhibited a decrease in ar-
ithmetic mean peak curvature (Spc) (Table S4). Smaller values of Spc
indicate that the surface peaks which form points of contact with other
objects have more rounded shapes, which coincides with a somewhat
smoother appearance of the coated surface on SEM images and suggests
that the collagen coating deposited on the surface was very thin.
In order to investigate the effect of the collagen coating on ion ex-
change between the ceramic and the medium, concentrations of cal-
cium and phosphorus in the medium were quantified by ICP-MS after
2d, 5d and 7d of cell culture (Fig. 4). While a difference in ion con-
centration was apparent between HA and TCP (as can be expected given
their different structure and composition), no significant effect of the
coating on calcium and phosphate concentration in the medium was
observed at any point. Profilometry analysis of the ceramic discs after
immersion for 7d in cell culture medium showed that the arithmetic
mean height (Sa) of HA discs showed a small increase, whereas that of
TCP, with more pronounced surface dynamics in terms of ion exchange,
showed a further small decrease (Table S4). This suggests that the
coating was not stable over the 7 day period.
Therefore, while the coated ceramics initially presented a different
surface chemistry to the hMSCs, their ability to exchange calcium and
phosphate ions with their surroundings was unaffected because the
coating was very thin and unstable.
hMSCs were cultured for 7 days in osteogenic medium on the coated
and uncoated ceramics, and the mRNA expression of ENPP1, BMP2,
OPN and ALP was analysed (Fig. 5). ALP expression levels increased
significantly on collagen-coated HA relative to uncoated HA. On the
other hand, ALP levels on coated TCP were reduced below the limit of
detection.
Levels of ENPP1 and the other two osteogenic markers, all of which
have previously shown upregulation on osteoinductive ceramics, did
not differ significantly between coated and uncoated HA. On the TCP
discs, a significantly lower level of OPN expression was observed on the
coated ceramic, while no significant difference was seen in the levels of
ENPP1 and BMP2 between coated and uncoated ceramic.
Overall, these results suggest that covering the surface chemistry of
an osteoinductive ceramic with collagen has limited, if any, effects on
the response of cells to the ceramic.
3.5. The effect of surface microstructure on the expression of ENPP1
Surface microstructure is known to be important in determining
whether a ceramic is osteoinductive. Osteoinductive BCP1150 and non-
osteoinductive BCP1300 differ only in their microstructure and not in
their chemistry [3,18,19]. Non-osteoinductive HA and osteoinductive
Fig. 2. A: mRNA expression (mean ± SD, n=3) of ENPP1 in hMSCs cultured on different ceramics in osteogenic medium, relative to expression on HA. No
significant difference is observed after 8 h, while after 48 h there is an increase in expression in cells cultured on TCP. After 7 d, ENPP1 is significantly upregulated on
both osteoinductive ceramics relative to non-osteoinuctive ceramics. B and C: Levels of PC-1 protein expression (mean ± SD, n = 4) by Western blot quantification,
normalised to GAPDH, in hMSCS cultured on different ceramics in osteogenic medium. No significant differences were observed after 8 h and 48 h, while after 7d the
expression levels were significantly higher in cells cultured on osteoinductive ceramics than in those cultured on non-osteoinductive ceramics. Significance levels:
*p < 0.05, **p < 0.01, ***p < 0.001 (One-way ANOVA with Tukey's post-hoc test).
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Fig. 3. Immunohistochemical staining of PC-1
(green) on decalcified histological sections of hMSCs
cultured on HA (A), BCP1300 (B), TCP (C) and
BCP1150 (D). PC-1+ staining is observed only in
cells in direct contact with osteoinductive materials,
not in cells distant from the surface or cultured on
non-osteoinductive materials. Image E is an en-
largement of image C. Nuclei are stained in blue. All
scale bars are 500 μm. Images are representative re-
sults from at least three independent experiments
using hMSCs from two different donors. (For inter-
pretation of the references to colour in this figure
legend, the reader is referred to the Web version of
this article.)
Fig. 4. Concentrations of Ca and P in cell culture medium after 2, 5 and 7 days of hMSC culture on collagen-coated and uncoated HA and TCP discs, measured by ICP-
MS, relative to fresh medium from the same batch (dashed line). Collagen coating did not appreciably affect exchange of ions with the medium. Error bars indicate SD
(n=3, two-way ANOVA with Tukey's post-hoc test).
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TCP are chemically different and also differ in their surface structure
[30]. Therefore, we aimed to decouple surface structure from surface
chemistry and investigate the role of structure alone on the expression
of ENPP1, BMP2, OPN and ALP.
The surface structures of HA and TCP ceramic discs were replicated
effectively and with high fidelity in a polystyrene film using previously
described micromoulding techniques [31,33]. hMSCs were cultured on
these replicas and on the original ceramic discs, as well as on flat
polystyrene as a control, for 7 days in osteogenic medium. With the
exception of ALP, which was upregulated on the polystyrene replica of
TCP, osteogenic markers were not significantly upregulated on the
polystyrene replicas compared to flat polystyrene controls (Fig. 6).
These results suggest that surface structure in the absence of CaP
chemistry is not sufficient for osteogenic differentiation of hMSCs or for
the expression of ENPP1, BMP2 and OPN.
3.6. Correlation between ENPP1 and BMP2 expression
To investigate the correlation between ENPP1/PC-1 expression and
other markers of osteogenic differentiation, the expression of ENPP1 in
hMSCs was suppressed using shRNA. hMSCs with shRNA-targeted
ENPP1 knockdown were cultured on osteoinductive TCP particles in
osteogenic medium for 7 days. The effectiveness of the knockdown in
reducing ENPP1 expression and PC-1 production was validated by RT-
qPCR and Western blotting (Fig. 7).
In cells with suppressed ENPP1 expression, BMP2 mRNA expression
significantly increased, while BMP2 protein production also showed an
increase. In contrast, levels of OPN and ALP mRNA significantly de-
creased. These data suggest that targeting ENPP1 for knockdown in
hMSCs cultured on osteoinductive ceramics enhances BMP2 expression
at both mRNA and protein levels, while reducing ALP and OPN ex-
pression.
4. Discussion
CaP-based ceramics have been used in the treatment of large bone
defects for the last five decades [21]. However, they have still not
completely replaced natural bone grafts such as autografts. Such com-
prehensive replacement has only been considered possible since it was
demonstrated that some CaP ceramics, depending on their chemical and
physical properties, have the ability to induce new bone formation even
at heterotopic implantation sites [20]. For example, in one study an
Fig. 5. mRNA expression (mean ± SD, n=3) of ENPP1, BMP2, OPN and ALP in hMSCs cultured on HA and TCP discs, either uncoated or coated with a collagen
layer, after 7 d culture in osteogenic medium. Values are relative to uncoated HA. On non-osteoinductive HA, collagen coating of the ceramic significantly increased
ALP expression, while there was a non-significant trend towards a decrease in the other three osteogenic markers. On osteoinductive TCP, collagen coating resulted in
a significantly lower level of OPN expression, but no significant change in ENPP1 and BMP2 expression. ALP mRNA could not be detected in cells cultured on coated
TCP. All data are normalised against GAPDH. *p > 0.05, **p > 0.01 (One-way ANOVA, Tukey's post-hoc test).
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osteoinductive TCP ceramic was shown both to induce heterotopic bone
formation and to be as effective as autografted bone in regenerating a
17mm iliac wing bone defect in sheep [30].
Despite this and several other successful examples of osteoinductive
CaP ceramics [20], the development of these ceramics has not yet made
the use of natural bone grafts obsolete. For instance, osteoinductive CaP
ceramics are inherently brittle due to their porosity, and it has not yet
been possible to improve their mechanical properties without com-
promising their bioactivity. In addition, the rate of new bone formation
still needs to be better controlled so that it matches the degradation rate
of the ceramic in vivo.
The research and development efforts needed to solve these pro-
blems would benefit from an improved understanding of the me-
chanism of osteoinduction. Knowledge of the role of individual material
properties in determining whether, and to what extent, a CaP ceramic is
osteoinductive would open the way towards rational design of these
materials with improved properties. In an attempt to shed light on this
mechanism, the starting point of this study was a full proteome analysis
of clinically relevant hMSCs on a set of four CaP ceramics known to be
osteoinductive or non-osteoinductive. The physical and chemical
properties of these ceramics, their in vivo bone forming potential, and
their effect on the expression of osteogenic markers at mRNA level,
have already been described [4,30,46,47].
The proteome analysis in the current study identified PC-1 as a
protein of interest. Notably, none of the classical osteoblast markers
such as BMP2, OPN, runt-related transcription factor 2 (RUNX2), ALP
and bone gamma carboxyglutamate protein (BGLAP) were found to be
differentially expressed on osteoinductive versus non-osteoinductive
CaP ceramics. However, these markers were also not observed in an
earlier proteomic study of osteoblasts cultured on tissue culture poly-
styrene [48]. That study attributed the lack of detection to low abun-
dance of these proteins, potentially below the detection limit of the LC-
MS/MS device, which may also explain why they do not appear in the
list of differentially expressed proteins in this proteomic analysis. The
overexpression of ENPP1/PC-1 on osteoinductive relative to non-os-
teoinductive CaP ceramics was validated using RT-qPCR, Western blot
analysis, and immunohistochemical staining.
The role of ENPP1 in regulation of tissue mineralisation is well es-
tablished. Mice with a truncation mutation in the ENPP1 gene resulting
in loss of function, also known as the “tiptoe walking” (ttw/ttw) muta-
tion, exhibit symptoms of heterotopic tissue mineralisation including
peri-articular and articular calcifications and progressive fusion of
spinal ligaments [49]. A similar phenotype has been observed in mice
where the ENPP1 gene has been knocked down [50]. In humans, mu-
tations in the ENPP1 gene are linked to general arterial calcification of
infancy (GACI), a disorder characterised by the calcification of arteries
before birth or within the first few months of life [41,51].
PC-1 is the main enzyme involved in the generation of extracellular
Fig. 6. mRNA expression (mean ± SD) of ENPP1, BMP2, OPN and ALP in cells cultured on HA and TCP discs and on polystyrene structural replicas of these discs for
7 d in osteogenic medium, relative to cells cultured on flat polystyrene discs as a control. Expression of ENPP1, BMP2 and OPN was significantly downregulated on
polystyrene replicas of both HA and TCP compared to the corresponding ceramic discs, an effect which was more pronounced for ENPP1 and BMP2 on TCP.
Expression of ALP mRNA was higher on replicas than on ceramics. No significant difference was observed between replicas and flat polystyrene. All data were
normalised to GAPDH mRNA. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way ANOVA, Tukey's post-hoc test).
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PPi by mature osteoblasts and chondrocytes [52,53], which is im-
portant in the regulation of hard and soft tissue mineralisation [42]. As
PPi inhibits HA precipitation, ENPP1 acts to negatively regulate mi-
neralisation by producing PPi. However, PPi is also hydrolysed by
TNAP to yield Pi, which is a precursor to bone mineral. The interplay of
the activities of PC-1, TNAP, Ank, PiT-1 and PHOSPHO1 regulates the
Pi/PPi ratio both inside and outside cells, preventing calcification of
soft tissues by keeping the concentration of extracellular PPi high, while
inducing bone mineralisation by hydrolysing PPi to Pi [54]. In addition,
a recent study in mice has shown that ENPP1/PC-1 negatively regulates
the hedgehog signalling pathway [29] which is also important in en-
dochondral bone formation [55]. However, while the role of ENPP1 in
natural bone formation has been extensively described, to our knowl-
edge there is as yet no evidence of its role in the control of bone for-
mation induced or supported by CaP ceramics.
In addition to ENPP1, this study showed that expression of the os-
teogenic markers BMP2 and OPN increased significantly on os-
teoinductive compared to non-osteoinductive CaP ceramics, a result
that was in accordance with previous studies [4,56]. This effect was
also observed when the cells were cultured in basic rather than osteo-
genic medium, suggesting that osteogenic differentiation is triggered by
osteoinductive ceramic materials even in the absence of osteogenesis-
stimulating factors. In contrast to these three markers, the mRNA ex-
pression of ALP was low and did not vary significantly between cera-
mics. This is again in accordance with the previous finding that the
presence of CaP ceramics significantly decreases ALP expression,
especially in osteogenic medium [45].
Earlier studies on the interaction between these osteogenic markers
have shown that OPN expression is promoted by increased levels of PPi,
which is generated by PC-1 [57]. OPN, in turn, suppresses the deposi-
tion of HA crystals, inhibiting calcification [58]. In contrast, ALP de-
creases levels of PPi, thereby antagonising this inhibitory effect of PC-1
on ectopic calcification [59]. Silencing ENPP1 expression in hMSCs
resulted in the downregulation of both OPN and ALP. It is expected that
lower levels of PPi result in reduced OPN expression, while the de-
creased expression of ALP could be explained by a feedback mechanism
where lower levels of PPi result in less ALP being needed to hydrolyse it
to Pi.
Comparatively little is known about the interdependence of ENPP1/
PC-1 and BMP2. BMP2 plays an essential role in the differentiation of
MSCs towards bone, cartilage and connective tissue [60] and tran-
scriptionally regulates ALP, collagen type 1, osteocalcin and OPN [61].
Fig. 7. A: Expression levels (mean ± SD, n=3) of ENPP1, BMP2, OPN and ALP in hMSCs with suppressed ENPP1 cultured for 7 d on TCP particles in osteogenic
medium, relative to cells treated with a scrambled control shRNA (SCR). Data normalised to GAPDH. *p < 0.05 (Unpaired Student's t-test) B: Western blots of PC-1
and BMP-2 in hMSCs with suppressed ENPP1 and hMSCs treated with a scrambled control shRNA, cultured 7 d on TCP particles in osteogenic medium. Suppression of
ENPP1 increased expression of BMP2 at gene and protein levels while significantly decreasing OPN and ALP expression.
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Here, we found that silencing ENPP1 expression resulted in upregula-
tion of BMP2 expression at gene and protein levels in in vitro osteogenic
differentiation experiments.
We suggest that osteoinductive ceramics trigger the differentiation
of hMSCs into the osteogenic lineage and therefore the expression of
high levels of BMP2 and the onset of mineralisation. ENPP1 is expressed
in response to this process in order to restrict further mineralisation.
Therefore, silencing ENPP1 in cells cultured on osteoinductive materials
might result in a more pronounced osteogenic differentiation and faster
mineralisation in vitro.
We now consider the role of material properties in osteoinduction.
As described above, the balance between PPi and Pi is important in the
regulation of tissue mineralisation. This balance is also affected by the
presence of CaP ceramics in the system, as these materials undergo a
dynamic exchange of calcium and Pi with the cell culture medium. It
should be noted that cell culture medium and body fluids are both
supersaturated with respect to calcium and phosphate, so the dominant
process is adsorption or precipitation of these ions from the medium
onto the surface of the ceramic rather than dissolution of the ions from
the ceramic into the medium. We found a difference in levels of calcium
and phosphorus in the cell culture medium between osteoinductive TCP
and non-osteoinductive HA, particularly after 2 days, with a sig-
nificantly lower concentration of both elements in the presence of TCP-
a finding in accordance with previous results [62].
Interestingly, this study showed a heterogeneous distribution of PC-
1 in cells cultured on osteoinductive ceramics. Only cells in direct
contact with the ceramic surface, not those in the ceramic pores, ex-
hibited PC-1 positive staining. This suggests that direct contact with the
ceramic surface is important for osteoinduction, as observed in earlier
studies [12]. This effect could depend on the chemistry of the surface of
the surface, its microstructure, or variations in local concentrations of
soluble factors close to the surface.
We first investigated the importance of surface chemistry, by
coating the surfaces of both osteoinductive TCP and non-osteoinductive
HA with a collagen layer. No significant effect of the collagen coating
on expression levels of ENPP1 and other osteogenic markers was ob-
served, suggesting that replacing the CaP surface chemistry with that of
collagen does not affect the differentiation of cells towards the osteo-
genic lineage. It should however be noted that the collagen coating was
very thin, and probably unstable over a culture period of 7 days. This
means that the replacement of CaP surface chemistry by collagen was
only temporary, which may also explain why no significant differences
were observed in calcium and phosphorus concentrations in the
medium between the coated and uncoated ceramics. An experiment
with a more stable coating that is able to affect ion exchange between
the medium and the ceramics is needed to conclusively prove that re-
placement of the CaP surface chemistry with collagen does not affect
the osteogenic differentiation of hMSCs.
Next, the effect of surface structure on osteogenic differentiation
was investigated by replicating the surface microstructure of os-
teoinductive TCP and non-osteoinductive HA in polystyrene using mi-
cromoulding. Cell culture experiments showed a marked decrease in
mRNA expression of ENPP1, BMP2 and OPN on the polystyrene replicas
compared to the ceramic originals, and no difference in expression le-
vels of these markers between the replicas of different ceramics. These
results showed that microstructure alone, in the absence of CaP, is not
sufficient to trigger osteogenic differentiation. While these findings are
in accordance with previous results regarding the expression of osteo-
genic markers by hMSCs cultured on polymer replicas of various cal-
cium phosphate crystals [31], another study has shown that HA sur-
faces retain their positive effect on the expression of osteogenic markers
after sputter-coating with gold to completely cover the surface [63].
Other studies have also shown that differentiation of hMSCs towards
the osteogenic lineage can be triggered by nanotopographies fabricated
from PMMA [64] or titanium [65], though neither of these studies
measured an increase in ENPP1 or BMP2. In our study, structural
ceramic replicas in polystyrene could not trigger the osteogenic dif-
ferentiation, however, we have demonstrated the importance of surface
microstructure in CaP ceramics. PC-1 expression was detected in cells in
direct contact with the surface of the osteoinductive BCP1150, but not
in the non-osteoinductive BCP1300. While these two ceramics are
chemically identical, their microstructure is significantly different.
Taken together, these results support the hypothesis that a localised
process involving exchange of calcium and phosphate ions between the
medium (or body fluids) and the material is important for osteoinduc-
tion by CaP ceramics. In particular, given the supersaturation of cell
culture medium with respect to these ions, we suggest that the me-
chanism involves localised depletion of calcium and/or phosphate ions
as apatite is formed on the surface. Cells in direct contact with the
material are most exposed to this localised depletion, and are the ones
being triggered to differentiate into the osteogenic lineage first. As has
been recently hypothesised [22], the microstructure of the material is
important in determining whether there is sufficient replenishment of
depleted ions from the bulk solution; insufficient replenishment will
trigger an osteoinductive response, while sufficient replenishment will
not. The results from the collagen-coated ceramics, that should be taken
with caution because of the low thickness of the coating, could be ex-
plained by the fact that, though the CaP ceramic surface chemistry has
been replaced, collagen is also a potential nucleation site for HA crys-
tallisation, so a material with the microstructure of an osteoinductive
CaP ceramic and the surface chemistry of collagen can itself be os-
teoinductive. On the other hand, the polystyrene replicas have the re-
quisite microstructure but cannot nucleate HA crystallisation.
In this work, we focused on the role of chemistry and micro-
structure, based on the known mechanisms of ENPP1/PC1. However, it
cannot be ignored that, by introducing a different chemistry, either
through collagen coating or by replication in polystyrene, other prop-
erties of the surface, such as mechanical properties and wettability, may
also change. Substrate stiffness versus CaP chemistry has previously
been studied by Mattei and co-authors, who suggested that the presence
of CaP has a stronger effect on osteogenic differentiation of human
periosteum derived progenitor cells, but also that this effect can be
enhanced by controlling substrate stiffness [66]. In our study, the CaP
ceramics as well as their replicas in polystyrene are hard materials and
it is not expected that they would have different mechanical effects on
cells. Regarding collagen, in an earlier study it was shown that cells can
sense the stiffness of the underlying substrate through a thin layer of
collagen, suggesting that the mechanical effect of the collagen itself is
limited. Nevertheless, in a paper by Mullen et al. it has been empha-
sized that a complex combination of the effects of substrate modulus,
thickness, and microstructure needs to be taken into account to de-
termine the mechanical forces experienced at the cellular level and
therefore the mechanical effect of the collagen layer on cells cannot be
fully excluded [67].
Wettability of the surface and specific surface area are also im-
portant, especially for the initial protein binding from serum-containing
cell culture medium. We observed that both TCP and collagen-coated
TCP immediately absorbed water droplets during contact angle mea-
surements, because of their microporosity. Coating HA discs (contact
angle 75.8° ± 10.8°) with collagen rendered them more hydrophilic
(41.2° ± 4.8°). In contrast, polystyrene replicas were more hydro-
phobic, having a contact angle of 94.2°± 9.8° (Table S5). These dif-
ferences, along with differences in the accessible surface area, could
affect the quantity as well as the type and conformation of proteins
binding to the surface, which in turn may affect cell attachment and
subsequent biological processes and is a topic of further investigation.
In summary, this study describes for the first time a role for ENPP1/
PC-1 in the osteogenic differentiation of hMSCs cultured on os-
teoinductive CaP ceramics. ENPP1/PC-1 was found to be expressed
exclusively in cells in direct contact with the surface of osteoinductive
ceramics, suggesting that it is expressed in response to a, probably
chemically-driven, process occurring at the surface. In addition, cells in
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which ENPP1 had been silenced expressed increased levels of BMP2,
suggesting that ENPP1 acts to negatively regulate BMP2 expression as
part of an inhibitory response to osteogenic differentiation and ectopic
mineralisation at the surface of a ceramic.
This study provides important information about the interplay of
genes and proteins involved in the regulation of the osteoinductive
response to biomaterials, and also serves as supporting evidence for the
theory that localised depletion of calcium and Pi ions is responsible for
osteoinduction. This is useful knowledge for the rational design of fu-
ture synthetic bone graft substitutes. Further work is needed to describe
later events in the process of osteoinduction and biomineralisation at
the protein level, and to elucidate the role of ENPP1 in later stages of
the mechanism. For instance, it is as yet unknown whether ENPP1 has
any role in extracellular matrix production, and longer-term cell culture
experiments will be necessary to elucidate this. The chemistry occurring
at the ceramic surface should be studied to determine exactly what
leads to the differentiation of cells into the distinct PC-1+ subpopula-
tion described in this study. Finally, in vivo osteoinduction experiments
are important to conclusively demonstrate the importance of ENPP1 in
osteoinduction by biomaterials.
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